Is Dosing of Therapeutic Immunoglobulins Optimal? A Review of a Three-Decade Long Debate in Europe-Reference-Cited by-同舟云学术

Is Dosing of Therapeutic Immunoglobulins Optimal? A Review of a Three-Decade Long Debate in Europe

Published:2014-12-12 Issue: Volume:5 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Kerr Jacqueline,Quinti Isabella,Eibl Martha,Chapel Helen,SpÃ¤th Peter J.,Sewell W. A. Carrock,Salama Abdulgabar,van Schaik Ivo N.,Kuijpers Taco W.,Peter Hans-Hartmut

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference193 articles.

1. Global plasma demand in 2015;Robert,2009

2. Serum trough IgG level and annual intravenous immunoglobulin dose are not related to body size in patients on regular replacement therapy;Khan;Drug Metab Lett,2011

3. Impact of ideal body weight dosing for all inpatient i.v. immune globulin indications;Rocchio;Am J Health Syst Pharm,2013

4. Home-based subcutaneous immunoglobulin versus hospital-based intravenous immunoglobulin in treatment of primary antibody deficiencies: systematic review and meta analysis;Abolhassani;J Clin Immunol,2012

5. Why I use subcutaneous immunoglobulin (SCIG);Shapiro;J Clin Immunol,2013

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Navigating the Asia‐Pacific region plasma therapies landscape: Insights from the 2023 Asia‐Pacific Plasma Leaders' Network meetings;Vox Sanguinis;2024-08-19

2. Dose–exposure–efficacy response of intravenous immunoglobulin G 10% in multifocal motor neuropathy;Annals of Clinical and Translational Neurology;2024-07-08

3. Shortage of plasma-derived medicinal products: what is next? narrative literature review on its causes and counteracting policies in Italy;Frontiers in Pharmacology;2024-05-06

4. Immune-Targeted Therapies in SSc;Scleroderma;2024

5. Anwendung von humanen Immunglobulinpräparaten bei Lieferengpässen;Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz;2023-09-28